AAAAAA
Results: 1-25/30
Authors:
Blinov, BB
Derbenev, YS
Kageya, T
Kantsyrev, DY
Krisch, AD
Morozov, VS
Sivers, DW
Wong, VK
Anferov, VA
Schwandt, P
von Przewoski, B
Citation: Bb. Blinov et al., Spin flipping with an rf dipole and a full Siberian snake (vol 3, art. no.104001, 2000), PHY R SPE T, 4(3), 2001, pp. NIL_18-NIL_18
Authors:
Brunner, J
Parhofer, KG
Schwandt, P
Bronisch, T
Citation: J. Brunner et al., Cholesterol, omega-3 fatty acids, and suicide risk: Empirical evidence andpathophysiological hypotheses, F NEUR PSYC, 69(10), 2001, pp. 460-467
Authors:
Geiss, HC
Parhofer, KG
Schwandt, P
Citation: Hc. Geiss et al., Parameters of childhood obesity and their relationship to cardiovascular risk factors in healthy prepubescent children, INT J OBES, 25(6), 2001, pp. 830-837
Authors:
Ohrig, E
Geiss, HC
Haas, GM
Schwandt, P
Citation: E. Ohrig et al., The Prevention Education Program (PEP) Nuremberg: design and baseline dataof a family oriented intervention study, INT J OBES, 25, 2001, pp. S89-S92
Authors:
Zachoval, R
Gerbes, AL
Schwandt, P
Parhofer, KG
Citation: R. Zachoval et al., Short-term effects of statin therapy in patients with hyperlipoproteinemiaafter liver transplantation: results of a randomized cross-over trial, J HEPATOL, 35(1), 2001, pp. 86-91
Authors:
Geiss, HC
Otto, C
Schwandt, P
Parhofer, KG
Citation: Hc. Geiss et al., Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects, METABOLISM, 50(8), 2001, pp. 983-988
Authors:
Otto, C
Ritter, MM
Richter, WO
Minkenberg, R
Schwandt, P
Citation: C. Otto et al., Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks, METABOLISM, 50(2), 2001, pp. 166-170
Authors:
Schwandt, P
Siegenthaler, W
Citation: P. Schwandt et W. Siegenthaler, The myocardial infarction, INTERNIST, 42(9), 2001, pp. 1187-1188
Authors:
Frost, RJA
Otto, C
Geiss, HC
Schwandt, P
Parhofer, KG
Citation: Rja. Frost et al., Effects of Atorvastatin versus Fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters intype 2 diabetes mellitus with mixed hyperlipoproteinemia, AM J CARD, 87(1), 2001, pp. 44-48
Authors:
Empen, K
Otto, C
Muller-Hocker, J
Zapf, J
Schwandt, P
Citation: K. Empen et al., Case 1. Hypoglycemic syncope due to a peripheral neuroectodermal tumor, J CL ONCOL, 18(7), 2000, pp. 1594-1596
Authors:
Laubach, E
Schwandt, P
Ritter, MM
Citation: E. Laubach et al., Neutral protamine Hagedorn insulin, LANCET, 355(9199), 2000, pp. 236-236
Authors:
Otto, C
Richter, WO
Schwandt, P
Citation: C. Otto et al., Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: Evaluation by selective depletion of low-density lipoproteins or fibrinogen, METABOLISM, 49(6), 2000, pp. 810-813
Authors:
Schamberger, BM
Geiss, HC
Ritter, MM
Schwandt, P
Parhofer, KG
Citation: Bm. Schamberger et al., Influence of LDL apheresis on LDL subtypes in patients with coronary heartdisease and severe hyperlipoproteinemia, J LIPID RES, 41(5), 2000, pp. 727-733
Authors:
Parhofer, KG
Barrett, PHR
Demant, T
Schwandt, P
Citation: Kg. Parhofer et al., Acute effects of low density lipoprotein apheresis on metabolic parametersof apolipoprotein B, J LIPID RES, 41(10), 2000, pp. 1596-1603
Authors:
Parhofer, KG
Barrett, PHR
Schwandt, P
Citation: Kg. Parhofer et al., Atorvastatin improves postprandial lipoprotein metabolism in normolipidemic subjects, J CLIN END, 85(11), 2000, pp. 4224-4230
Authors:
Otto, C
Schwandt, P
Citation: C. Otto et P. Schwandt, More on atorvastatin and fibrinogen, ATHEROSCLER, 151(2), 2000, pp. 591-592
Authors:
Empen, K
Otto, C
Parhofer, KG
Bosch, T
Schwandt, P
Citation: K. Empen et al., Acute edematous pancreatitis in chylomicronemia due to lipoproteinase deficiency, INTERNIST, 41(10), 2000, pp. 1099-1102
Authors:
Laubach, E
Otto, C
Schwandt, P
Citation: E. Laubach et al., Toward better therapy at hypercholesterolemia, ARCH IN MED, 160(17), 2000, pp. 2685-2686
Authors:
Geiss, HC
Parhofer, KG
Schwandt, P
Citation: Hc. Geiss et al., Atorvastatin compared with simvastatin in patients with severe LDL hypercholesterolaemia treated by regular LDL apheresis, J INTERN M, 245(1), 1999, pp. 47-55
Authors:
Schwandt, P
Geiss, HC
Ritter, MM
Ublacker, C
Parhofer, KG
Otto, C
Laubach, E
Donner, MG
Haas, GM
Richter, WO
Citation: P. Schwandt et al., The prevention education program (PEP), a prospective study of the efficacy of family-oriented life style modification in the reduction of cardiovascular risk and disease: Design and baseline data, J CLIN EPID, 52(8), 1999, pp. 791-800
Authors:
Carman, DS
Bland, LC
Chant, NS
Gu, T
Huber, GM
Huffman, J
Klyachko, A
Markham, BC
Roos, PG
Schwandt, P
Solberg, K
Citation: Ds. Carman et al., Quasifree inclusive and exclusive analyzing powers at 200 MeV, PHYS REV C, 59(4), 1999, pp. 1869-1877
Authors:
Carman, DS
Bland, LC
Chant, NS
Gu, T
Huber, GM
Huffman, J
Klyachko, A
Markham, BC
Roos, PG
Schwandt, P
Solberg, K
Citation: Ds. Carman et al., Quasifree inclusive and exclusive cross sections at 200 MeV, PHYS LETT B, 452(1-2), 1999, pp. 8-14
Authors:
Carman, DS
Bland, LC
Chant, NS
Eads, A
Gu, T
Huber, GM
Huffman, J
Klyachko, A
Markham, BC
Roos, PG
Schwandt, P
Solberg, K
Citation: Ds. Carman et al., A neutron detector for (p,np) coincidence studies, NUCL INST A, 430(2-3), 1999, pp. 382-399
Authors:
Donner, MG
Parhofer, KG
Richter, WO
Schwandt, P
Citation: Mg. Donner et al., Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis, METABOLISM, 48(7), 1999, pp. 881-886
Authors:
Parhofer, KG
Demant, T
Ritter, MM
Geiss, HC
Donner, M
Schwandt, P
Citation: Kg. Parhofer et al., Lipoprotein (a) metabolism estimated by nonsteady-state kinetics, LIPIDS, 34(4), 1999, pp. 325-335